$PET
Wag! Group Co. Stock $pet

$pet Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000162828022029536 Filed on November 10, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$17.04M	$15.38M	$0.00
YoY Change
Cost Of Revenue	$1.114M	$3.877M
YoY Change
Gross Profit	$15.92M	$11.50M
YoY Change
Gross Profit Margin	93.46%	74.79%
Selling, General & Admin	$17.04M	$35.07M	$712.4K
YoY Change	2292.06%	33541.25%
% of Gross Profit	107.03%	304.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$140.0K	$134.0K
YoY Change		9.84%
% of Gross Profit	0.88%	1.17%
Operating Expenses	$17.18M	$35.07M	$712.4K
YoY Change	2311.71%	33541.25%
Operating Profit	-$1.260M	-$23.57M
YoY Change		22508.37%
Interest Expense	-$1.686M	-$735.0K	$3.000K
YoY Change	-56300.0%	-8266.67%
% of Operating Profit
Other Income/Expense, Net	$8.750M	-$13.71M
YoY Change
Pretax Income	$5.804M	-$40.93M	-$709.4K
YoY Change	-918.11%	39162.35%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$5.804M	-$40.93M	-$709.4K
YoY Change	-918.11%	39162.73%
Net Earnings / Revenue	34.07%	-266.15%
Basic Earnings Per Share		-$1.67
Diluted Earnings Per Share	$0.15	-$1.67	-$45.22K
COMMON SHARES
Basic Shares Outstanding	36.78M shares	37.92M	15.69M
Diluted Shares Outstanding		24.53M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.97M	$28.02M	$687.6K
YoY Change	5567.12%	3021.34%
Cash & Equivalents	$38.97M	$28.02M	$687.6K
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$2.585M	$28.27M	$286.7K
YoY Change	801.67%	9734.09%
Inventory
Prepaid Expenses
Receivables	$5.872M	$6.336M	$2.638M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$47.42M	$62.63M	$1.043M
YoY Change	4447.4%	4895.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$88.00K	$67.00K	$90.00K
YoY Change	-2.22%
Goodwill	$1.451M	$1.427M	$1.427M
YoY Change	1.68%
Intangibles	$2.541M	$2.517M	$2.888M
YoY Change	-12.02%
Long-Term Investments			$125.0M
YoY Change
Other Assets	$64.00K	$78.00K	$191.4K
YoY Change	-66.57%	-70.4%
Total Long-Term Assets	$4.888M	$4.352M	$125.2M
YoY Change	-96.1%	-96.53%
TOTAL ASSETS
Total Short-Term Assets	$47.42M	$62.63M	$1.043M
Total Long-Term Assets	$4.888M	$4.352M	$125.2M
Total Assets	$52.31M	$66.99M	$126.2M
YoY Change	-58.56%	-47.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.174M	$4.961M	$583.3K
YoY Change	1129.83%	4367.2%
Accrued Expenses	$4.765M	$5.556M	$4.601M
YoY Change	3.56%
Deferred Revenue	$2.232M	$2.186M	$1.888M
YoY Change	18.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$1.264M	$1.169M	$442.0K
YoY Change	185.97%
Total Short-Term Liabilities	$16.49M	$34.60M	$583.3K
YoY Change	2727.04%	22361.6%
LONG-TERM LIABILITIES
Long-Term Debt	$24.97M	$24.49M	$0.00
YoY Change
Other Long-Term Liabilities	$928.0K	$651.0K	$4.375M
YoY Change	-78.79%	-85.12%
Total Long-Term Liabilities	$24.97M	$24.49M	$4.375M
YoY Change	470.74%	459.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.49M	$34.60M	$583.3K
Total Long-Term Liabilities	$24.97M	$24.49M	$4.375M
Total Liabilities	$42.39M	$59.75M	$4.958M
YoY Change	754.9%	1219.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$148.4M	-$154.2M	-$3.721M
YoY Change	3887.79%	5019.66%
Common Stock	$4.000K	$4.000K	$318.00
YoY Change	1157.86%	1157.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.922M	$7.237M	-$3.721M
YoY Change
Total Liabilities & Shareholders Equity	$52.31M	$66.99M	$126.2M
YoY Change	-58.56%	-47.05%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	$5.804M	-$40.93M	-$709.4K
YoY Change	-918.11%	39162.73%
Depreciation, Depletion And Amortization	$140.0K	$134.0K
YoY Change		9.84%
Cash From Operating Activities	$775.0K	-$3.059M	-$167.2K
YoY Change	-563.41%	395.76%
INVESTING ACTIVITIES
Capital Expenditures	$15.00K	$36.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$102.0K	$1.988M	$0.00
YoY Change		-101.59%
Cash From Investing Activities	-$117.0K	$1.952M	$0.00
YoY Change		-101.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.44M	51.52M	-43.00K
YoY Change	33469.77%	-59.27%
NET CHANGE
Cash From Operating Activities	775.0K	-3.059M	-167.2K
Cash From Investing Activities	-117.0K	1.952M	0.000
Cash From Financing Activities	-14.44M	51.52M	-43.00K
Net Change In Cash	-13.78M	50.42M	-210.2K
YoY Change	6452.99%	5644.19%
FREE CASH FLOW
Cash From Operating Activities	$775.0K	-$3.059M	-$167.2K
Capital Expenditures	$15.00K	$36.00K
Free Cash Flow	$760.0K	-$3.095M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001842356
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40764
	dei	Entity Registrant Name EntityRegistrantName	WAG! GROUP CO.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2546501
	dei	Entity Address Address Line1 EntityAddressAddressLine1	55
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Francisco Street,
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 360
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94133
	dei	City Area Code CityAreaCode	707
	dei	Local Phone Number LocalPhoneNumber	324-4219
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36782888	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28024000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2845000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	24719000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	2554000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6336000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2638000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3554000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3043000	usd
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	930000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	62633000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	12010000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	263000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2517000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2888000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1427000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1427000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	78000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	47000	usd
CY2022Q3	us-gaap	Assets Assets	66985000	usd
CY2021Q4	us-gaap	Assets Assets	16462000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4961000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2299000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5556000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4601000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2186000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1888000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	750000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	750000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	313000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1169000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	442000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	19668000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	34603000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9980000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	7800000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	7800000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24494000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1200000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	651000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1130000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	59748000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	12310000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	24545386	shares
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	23858824	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23858824	shares
CY2021Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	67417000	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	43763126	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38095337	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6121253	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	161454000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3736000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154221000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109850000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	7237000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-106113000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66985000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16462000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15379000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37829000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12036000	usd
CY2022Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1021000	usd
CY2021Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	861000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3027000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1934000	usd
CY2022Q3	pet	Platform Operations And Support Expense PlatformOperationsAndSupportExpense	5641000	usd
CY2021Q3	pet	Platform Operations And Support Expense PlatformOperationsAndSupportExpense	2508000	usd
	pet	Platform Operations And Support Expense PlatformOperationsAndSupportExpense	11035000	usd
	pet	Platform Operations And Support Expense PlatformOperationsAndSupportExpense	7768000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11290000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3151000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24656000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4991000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23781000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1972000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28546000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4968000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.67
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134000	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	122000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	431000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	232000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	41867000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	8614000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	67695000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	19893000	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-13708000	usd
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-13708000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3482000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3482000	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-735000	usd
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	9000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-784000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-5000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40931000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	757000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44358000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4380000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-797000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-793000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-40931000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	1554000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-44371000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3587000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.67
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24534325	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5885755	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12322230	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5616077	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24534325	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37473059	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12322230	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5616077	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23858824	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-106113000	usd
	pet	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	1100000	shares
	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	10925000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3440000	usd
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	24958824	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	121190000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-109459000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	55000	usd
CY2022Q3	pet	Stock Issued During Period Value Reverse Recapitalization Contingent Consideration Equity StockIssuedDuringPeriodValueReverseRecapitalizationContingentConsiderationEquity	23867000	usd
CY2022Q3	pet	Stock Issued During Period Value Reverse Recapitalization Contingent Consideration Equity StockIssuedDuringPeriodValueReverseRecapitalizationContingentConsiderationEquity	23867000	usd
CY2022Q3	pet	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	10544000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-40931000	usd
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	7237000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23858824	shares
	us-gaap	Net Income Loss NetIncomeLoss	-5141000	usd
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-100192000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	122000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23858824	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-105210000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	166000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	60000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	1554000	usd
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23858824	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-103430000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-44371000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3587000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	24016000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	182000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-14000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3482000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-141000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-792000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	431000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	232000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1971000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	83000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-13708000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3698000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1866000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	512000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	687000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-879000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2662000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-233000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	19000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1674000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-897000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	298000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	35000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-148000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3578000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10350000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	15618000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2550000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	22083000	usd
	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	562000	usd
	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	1509000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1952000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4956000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	331000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	29445000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	10925000	usd
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	usd
	pet	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	11485000	usd
	pet	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51524000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49898000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5392000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2845000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7065000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52743000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1673000	usd
	us-gaap	Interest Paid Net InterestPaidNet	784000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	166000	usd
	pet	Non Cash Derivative Instrument Contingent Consideration NonCashDerivativeInstrumentContingentConsideration	5242000	usd
	pet	Non Cash Derivative Instrument Contingent Consideration NonCashDerivativeInstrumentContingentConsideration	0	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	121188000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgements, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items subject to estimates and assumptions include, but are not limited to, fair values of financial instruments, assumptions used in the valuation of common and preferred stock, valuation of stock- based compensation and warrants, and the valuation allowance for deferred income taxes. Actual results may differ from these estimates.</span></div>
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154200000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109900000	usd
CY2022Q3	us-gaap	Escrow Deposit EscrowDeposit	24700000	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, investments, and amounts at payment processors are potentially subject to concentration of credit risk. Such balances are maintained at financial institutions that management determines to be of high-credit quality. Cash accounts at each institution are insured by the Federal Deposit Insurance Corporation ("FDIC") up to certain limits. At times, such deposits may be in excess of the FDIC insurance limit. The Company has not experienced any losses on its deposits.</span></div>
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	1700000	usd
CY2021Q3	us-gaap	Advertising Expense AdvertisingExpense	1800000	usd
	us-gaap	Advertising Expense AdvertisingExpense	5200000	usd
	us-gaap	Advertising Expense AdvertisingExpense	2700000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsCertain reclassifications have been made to prior year financial information to conform to the current year presentation. In particular, certain Money market funds have been reclassified out of Short-term investments available for sale and into Cash and cash equivalents on the Condensed Consolidated Balance Sheet, and Statement of Cash Flows.
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
CY2022Q3	pet	Proceeds From Redemption Of Common Stock ProceedsFromRedemptionOfCommonStock	29100000	usd
CY2022Q3	pet	Proceeds From Redemption Of Common Stock Classified As Restricted Cash Current ProceedsFromRedemptionOfCommonStockClassifiedAsRestrictedCashCurrent	23900000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5000000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	91130	shares
CY2022Q3	pet	Number Of Lenders NumberOfLenders	2	lender
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	24700000	usd
CY2022Q3	pet	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2393378	shares
CY2022Q3	pet	Derivative Instrument Contingent Consideration Liability Price Per Share DerivativeInstrumentContingentConsiderationLiabilityPricePerShare	10.30
CY2022Q3	pet	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	28330000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5202000	usd
CY2022Q3	pet	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	12729000	usd
CY2022Q3	pet	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	9318000	usd
CY2022Q3	pet	Reverse Recapitalization Net ReverseRecapitalizationNet	11485000	usd
CY2022Q3	pet	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	6523530	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	122434	shares
CY2022Q3	pet	Stock Issued During Period Shares Reverse Recapitalization And Other StockIssuedDuringPeriodSharesReverseRecapitalizationAndOther	6645964	shares
CY2022Q3	pet	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	31100000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37745964	shares
CY2022Q3	pet	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2393378	shares
CY2022Q3	us-gaap	Shares Outstanding SharesOutstanding	30863283	shares
CY2022Q3	pet	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.97
CY2022Q3	pet	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P3Y
CY2022Q3	pet	Stock Issued During Period Value Reverse Recapitalization Contingent Consideration Equity StockIssuedDuringPeriodValueReverseRecapitalizationContingentConsiderationEquity	23900000	usd
CY2022Q3	pet	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	39500000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15379000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37829000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12036000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2200000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1900000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	19668000	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	-5960000	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-13708000	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	-19668000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2600000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	92000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	227000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	319000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11M
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.11
CY2019Q4	us-gaap	Income Tax Examination Estimate Of Possible Loss IncomeTaxExaminationEstimateOfPossibleLoss	1200000	usd
CY2022Q2	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	-1200000	usd
CY2022Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2021Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	800000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	272000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1250000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1738000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	25581000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28841000	usd
CY2022Q3	pet	Line Of Credit Facility Financial Covenants Minimum Liquidity LineOfCreditFacilityFinancialCovenantsMinimumLiquidity	5000000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	24545386	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	23858824	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23858824	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110265000	usd
CY2021Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	67417000	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	43763126	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38095337	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38095337	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6121253	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6121253	shares
CY2022Q3	pet	Common Stock Exchange Ratio CommonStockExchangeRatio	0.97
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	182000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23922000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	60000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24016000	usd
	pet	Number Of Lenders NumberOfLenders	2
CY2021Q3	pet	Fair Value Of Warrants Price FairValueOfWarrantsPrice	1.32
CY2022Q3	pet	Class Of Warrant Or Right Redemption Of Warrants Or Rights Reference Price ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice	16.50
	pet	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays	20	day
	pet	Class Of Warrant Or Right Redemption Of Warrants Or Rights Consecutive Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsConsecutiveTradingDays	30	day
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-793000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-40931000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	1554000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-44371000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3587000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24534325	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5885755	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12322230	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5616077	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24534325	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37473059	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12322230	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5616077	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.67
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.67
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	40712231	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31104287	shares
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0

Files In Submission

Name	View Source	Status
0001628280-22-029536-index-headers.html	Edgar Link	pending
0001628280-22-029536-index.html	Edgar Link	pending
0001628280-22-029536.txt	Edgar Link	pending
0001628280-22-029536-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pet-20220930.htm	Edgar Link	pending
pet-20220930.xsd	Edgar Link	pending
pet-20220930xex311.htm	Edgar Link	pending
pet-20220930xex312.htm	Edgar Link	pending
pet-20220930xex321.htm	Edgar Link	pending
pet-20220930_g1.jpg	Edgar Link	pending
pet-20220930_g2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
pet-20220930_cal.xml	Edgar Link	unprocessable
pet-20220930_def.xml	Edgar Link	unprocessable
pet-20220930_lab.xml	Edgar Link	unprocessable
pet-20220930_pre.xml	Edgar Link	unprocessable
pet-20220930_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PET
Wag! Group Co. Stock $pet

2022 Q4 Form 10-Q Financial Statement

#000162828022029536 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PET Wag! Group Co. Stock $pet

2022 Q4 Form 10-Q Financial Statement

#000162828022029536 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PET
Wag! Group Co. Stock $pet